At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Withdrawn from the US market prior to January 2025.

Oral Chemotherapy Drug Pharmacist Education

Oral Chemotherapy TOC Information

Farydak medication guide

Farydak -- Oral drug used for treatment of resistant multiple myeloma, rare inpatient use expected.  Non-formulary, not stocked, patient may use own supply in hospital.

Reviewed: 25 August 2015 (Farydak)

REMS (Farydak): View FDA REMS Info

• Micromedex
• UpToDate
• Lippincott Advisor